Pathological or preventative? Amyloid-β as an effector of innate immunity.

Authors

Oluwagbenro O Adesunloro, Amanda N Tuckey, Jonathon P Audia, Allyson E Shea

Published in

Infection and immunity. Volume 94. Issue 8. Pages e0008526. Aug 11, 2026. Epub Jun 26, 2026.

Abstract

Amyloid-β (Aβ)-mediated inflammation, neurotoxicity, and plaque formation in the brain have long been regarded as pathological hallmarks of Alzheimer's disease. However, emerging evidence indicates that Aβ also serves a normal physiological role in the innate immune defense against infectious agents. A growing body of literature supports the hypothesis that Aβ is produced in response to infection and is an antimicrobial peptide-like molecule capable of inhibiting microbial growth through mechanisms such as membrane disruption and microbial entrapment. Additionally, evidence positions Aβ as an innate immune effector that can induce pro-inflammatory signals during infection. In this minireview, we discuss the clinical, in vivo, and in vitro evidence supporting the antimicrobial and innate immune effector roles of Aβ in host defense. Collectively, these findings support a broader functional role for Aβ beyond its established association with Alzheimer's disease pathology.

PMID:
42360156
Bibliographic data and abstract were imported from PubMed on 14 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.